{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T21:02:25Z","timestamp":1771275745098,"version":"3.50.1"},"reference-count":7,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,14]],"date-time":"2025-08-14T00:00:00Z","timestamp":1755129600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,8,14]],"date-time":"2025-08-14T00:00:00Z","timestamp":1755129600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s10620-025-09313-3","type":"journal-article","created":{"date-parts":[[2025,8,14]],"date-time":"2025-08-14T20:11:12Z","timestamp":1755202272000},"page":"41-43","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Gaining the Upper Hand \u2013 Upadacitinib for Crohn\u2019s Disease with Ileostomy: A Real-World Gap Addressed"],"prefix":"10.1007","volume":"71","author":[{"given":"Luis","family":"Mench\u00e9n","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,8,14]]},"reference":[{"key":"9313_CR1","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1093\/ecco-jcc\/jjad205","volume":"18","author":"N Hammoudi","year":"2024","unstructured":"Hammoudi N, Sachar D, D\u2019Haens G, Reinisch W, Kotze PG, Vermeire S, Sch\u00f6lmerich J, Kamm MA, Griffiths A, Panes J, Ghosh S, Siegel CA, Bemelman W, O\u2019Morain C, Steinwurz F, Fleshner P, Mantzaris GJ, Sands B, Abreu MT, Dotan I, Turner D, Dignass A, Allez M. Outcomes and Endpoints of Postoperative Recurrence in Crohn\u2019s Disease: Systematic Review and Consensus Conference. J Crohns Colitis 2024;18:943\u2013957. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjad205.","journal-title":"J Crohns Colitis"},{"key":"9313_CR2","doi-asserted-by":"publisher","first-page":"jjaf041","DOI":"10.1093\/ecco-jcc\/jjaf041","volume":"19","author":"S Abushamma","year":"2025","unstructured":"Abushamma S, Yadete T, Nero N, Falloon K, Parker CE, Abreu MT, Ahuja V, Armuzzi A, Bemelman W, Bruining DH, Deepak P, Dignass A, Dotan I, Feagan BG, Fulmer C, Halfvarson J, Hart A, Holubar SD, Leong RW, Ma C, Magro F, McCurdy JD, Narula N, Pan\u00e9s J, Raine T, Regueiro M, Rogler G, Singh S, Sparrow MP, Spinelli A, Van Koughnett JA, Vuyyuru SK, Solitano V, Yuan Y, Jairath V, Rieder F. Definitions, diagnosis, and management of postoperative recurrence in Crohn\u2019s disease patients with permanent ileostomy-a systematic review and meta-analysis. J Crohns Colitis 2025;19:jjaf041. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjaf041.","journal-title":"J Crohns Colitis"},{"key":"9313_CR3","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1056\/NEJMoa2212728","volume":"388","author":"EV Loftus Jr","year":"2023","unstructured":"Loftus EV Jr, Pan\u00e9s J, Lacerda AP, Peyrin-Biroulet L, D\u2019Haens G, Panaccione R, Reinisch W, Louis E, Chen M, Nakase H, Begun J, Boland BS, Phillips C, Mohamed MF, Liu J, Geng Z, Feng T, Dubcenco E, Colombel JF. Upadacitinib Induction and Maintenance Therapy for Crohn\u2019s Disease. N Engl J Med. 2023;388:1966\u20131980. https:\/\/doi.org\/10.1056\/NEJMoa2212728.","journal-title":"N Engl J Med."},{"key":"9313_CR4","doi-asserted-by":"publisher","first-page":"2113","DOI":"10.1016\/S0140-6736(22)00581-5","volume":"399","author":"S Danese","year":"2022","unstructured":"Danese S, Vermeire S, Zhou W, Pangan AL, Siffledeen J, Greenbloom S, H\u00e9buterne X, D\u2019Haens G, Nakase H, Pan\u00e9s J, Higgins PDR, Juillerat P, Lindsay JO, Loftus EV Jr, Sandborn WJ, Reinisch W, Chen MH, Sanchez Gonzalez Y, Huang B, Xie W, Liu J, Weinreich MA, Panaccione R. Upadacitinib as induction and maintenance therapy for moderately to severely active ulcerative colitis: results from three phase 3, multicentre, double-blind, randomised trials. Lancet. 2022;399:2113\u20132128. https:\/\/doi.org\/10.1016\/S0140-6736(22)00581-5.","journal-title":"Lancet."},{"key":"9313_CR5","doi-asserted-by":"publisher","unstructured":"Loeb L, Farraye FA, Crosby S, et al. Patients with Crohn\u2019s Disease and Ileostomy Can Respond to Upadacitinib. Dig Dis Sci 2025. https:\/\/doi.org\/10.1007\/s10620-025-09125-5.","DOI":"10.1007\/s10620-025-09125-5"},{"key":"9313_CR6","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1080\/17425255.2023.2256216","volume":"19","author":"S Azuz","year":"2023","unstructured":"Azuz S, Poulsen JL, Vinter-Jensen L, Olesen AE. Drug absorption from oral formulations in patients with short bowel syndrome: a comprehensive update of the literature. Expert Opin Drug Metab Toxicol. 2023;19:577\u2013600. https:\/\/doi.org\/10.1080\/17425255.2023.2256216.","journal-title":"Expert Opin Drug Metab Toxicol."},{"key":"9313_CR7","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.14309\/ajg.0000000000002215","volume":"118","author":"SK Vuyyuru","year":"2023","unstructured":"Vuyyuru SK, Rieder F, Solitano V, Nguyen TM, Crowley E, Narula N, Singh S, Ma C, Jairath V. Patients With Crohn\u2019s Disease and Permanent Ileostomy Are Universally Excluded From Clinical Trials: A Systematic Review. Am J Gastroenterol. 2023;118:1285\u20131288. https:\/\/doi.org\/10.14309\/ajg.0000000000002215.","journal-title":"Am J Gastroenterol."}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-025-09313-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10620-025-09313-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-025-09313-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T20:03:53Z","timestamp":1771272233000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10620-025-09313-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,14]]},"references-count":7,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["9313"],"URL":"https:\/\/doi.org\/10.1007\/s10620-025-09313-3","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,14]]},"assertion":[{"value":"11 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"L. Mench\u00e9n has served as a speaker, consultant or advisory member for or has received unrestricted grants from MSD, Abbvie, Takeda, Johnsson and Johnsson, Pfizer, Biogen, Alfa-Sigma, Kern Pharma, Lilly, Adacyte, Tillotts, Dr. Falk Pharma, Ferring, Medtronic and General Electric.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}